Claritas Pharmaceuticals

0 followers

‌

Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.

Industries

Pharmaceutical

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Robert Farrell

President & CEO

Robert Farrell

Collapse

Nedira Frenkel

Director, Business Development

Yousif Sahly

Director, Quality Control

Gali Guzikevich

Director, Quality Assurance

Amos Rosenthal

Head, Chemistry

Iris Maimon

Director, Drug Development

Teams

Leadership Team

6 members

Similar companies

UtilizeCore

6 followers

Gartner

774 followers

USPS

76 followers

Poplin

90 followers

Kroll

41 followers

Furst Group

14 followers

Emory Healthcare

9 followers

Timor Magna Corp.

2 followers

TriMet

2 followers

Jeeves

5 followers

NatureWise

1 follower

Explore companies